[Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gan to kagaku ryoho. Cancer & chemotherapy

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 17431344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy

  2016cites this paper
• A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy

  2016influential citation
• A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity

  2013cites this paper
• Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.

  2013cites this paper
• Effects of calcium and magnesium on acute and chronic neurotoxicity caused by oxaliplatin: A meta-analysis

  2012cites this paper
• Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis.

  2012cites this paper
• The effect of diabetes on oxaliplatin-induced peripheral neuropathy.

  2012cites this paper
• Effects of Ketamine on the Balance of Ions Ca2+, Mg2+, Cu2+ and Zn2+ in the Ischemia-reperfusion Affected Spinal Cord Tissues in Rabbits

  2009cites this paper
• Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature.

  2009cites this paper
• Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?

  2008cites this paper
• Neurologic complications of chemotherapy agents

  2007cites this paper
• FOLFOX-6 Combination as the First-Line Treatment of Locally Advanced and/or Metastatic Pancreatic Cancer

  2007cites this paper